Mirati Therapeutics (NASDAQ:MRTX) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Other research analysts have also recently issued reports about the stock. Scotiabank upgraded shares of Mirati Therapeutics from an underperform rating to a sector perform […]
More Stories
Short Interest in Greenidge Generation Holdings Inc. 8.50% Senior Notes due 2026 (NASDAQ:GREEL) Rises By 114.3%
Greenidge Generation Holdings Inc. 8.50% Senior Notes due 2026 (NASDAQ:GREEL – Get Free Report) was the recipient of a significant...
Skyline Builders Group Holding (SKBL) Announces January 20th IPO
Skyline Builders Group Holding (SKBL) is planning to raise $6 million in an initial public offering (IPO) on the week...
Africa Energy (CVE:AFE) Trading Up 33.3% – Time to Buy?
Shares of Africa Energy Corp. (CVE:AFE – Get Free Report) rose 33.3% during trading on Thursday . The stock traded...
Revance Therapeutics, Inc. (NASDAQ:RVNC) Short Interest Down 14.6% in December
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) saw a significant decline in short interest in the month of December....
Short Interest in Newell Brands Inc. (NASDAQ:NWL) Drops By 15.0%
Newell Brands Inc. (NASDAQ:NWL – Get Free Report) saw a significant decrease in short interest during the month of December....
Plato Gold (CVE:PGC) Stock Price Down 20% – Here’s What Happened
Plato Gold Corp. (CVE:PGC – Get Free Report) traded down 20% during mid-day trading on Tuesday . The company traded...